期刊文献+

免疫细胞化学染色检查协助鉴别浆膜腔积液中转移性腺癌原发部位 被引量:6

The value of immunocytochemistry in the distinguishment of primary site of metastatic adenocarcinoma in effusions
暂未订购
导出
摘要 目的:探讨一组鉴别浆膜腔积液中转移性腺癌原发部位的抗体。方法:对31例浆膜腔积液转移性腺癌制备细胞蜡块切片作TTF-1、CA125、CK7、CK20免疫细胞化学染色,这些病例经组织学或结合临床资料证实:肺腺癌15例、卵巢腺癌10例、胃肠癌6例。结果:肺腺癌的阳性表达分别是TTF-1(73.3%)、CA125(26.7%)、CK7(73.3%)、CK20(0%),卵巢腺癌的阳性表达分别是TTF-1(0%)、CA125(70.0%)、CK7(100.0%)、CK20(0%),胃肠腺癌的阳性表达分别是TTF-1(0%)、CA125(16.7%)、CK7(0%)、CK20(100.0%)。TTF-1在肺腺癌的表达具有高度敏感性(73.3%)及特异性(100%),CA125在卵巢腺癌的表达也有较高的敏感性(70.0%),CK7(-)/CK20(+)在胃肠腺癌的表达100%。结论:联合检测TTF-1、CA125、CK7、CK20能有效鉴别浆膜腔积液中来自肺、卵巢、胃肠道的腺癌。 Objective: To investigae a panel of immunohistochemical stains to help differentiate from the primary sites of metastatic adenocarcinoma in serous effusions.Methods: Thirty-one cases of metastatic adenocarcinoma in serous effusions were confirmed by histologic diagnoses and/or clinical,including 15 adenocarcinoma of lung,10 adenocarcinoma of ovary,6 gastrointestinal adenocarcinoma.Paraffin-embedded cell block sections were immunostained for TTF-1,CA125,CK7 and CK20.Results: The positive expression of lung adenocarcinoma were TTF-1(73.3%),CA125(26.7%),CK7(73.3%),CK20(0%);Ovarian adenocarcinoma were positive for TTF-1(0%),CA125(70.0%),CK7(100.0%),CK20(0%),gastrointestinal adenocarcinoma were positive for TTF-1(0%),CA125(16.7%),CK7(0%),CK20(100.0%).TTF-1 expression in lung adenocarcinoma with high sensitivity and specificity of 73.3%,100%,CA125 expression in ovarian adenocarcinoma had a higher sensitivity of 70.0%,the combination of CK7 negativity/CK20 positivity was seen in 100% of gastrointestinal adenocarcinoma.Conclusion: The combination of TTF-1,CA125,CK7 and CK20 stains is useful in distinguishing metastatic adenocarcinoma in serous effusions from lung,ovary and gastrointestinal.
出处 《现代肿瘤医学》 CAS 2012年第4期822-824,共3页 Journal of Modern Oncology
关键词 免疫细胞化学 转移性腺癌 浆膜腔积液 细胞块 immunocytochemical metastatic adenodarcinomas serous cavity effusions cell blook
  • 相关文献

参考文献11

  • 1马博文.浆膜腔积液细胞病理学诊断[M]北京:人民军医出版社,200688-91.
  • 2Zhu W,Michael CW. Wtl,monoclonal CEA,TTF1,and CA125 antibodies in the differential diagnosis of lung,breast,and ovarian adenocarcinomas in serous effusions[J].Diagnostic Cytopathology,2007,(06):370-375.
  • 3Smojver-Jezek S,Vrabec-Branica B,Juros Z. Thyroid transcription factor-1 in pulmonary cytology[J].Acta Med Croatiea,2008,(04):373-378.
  • 4Metzgeroth G,Kuhn C,Schultheis B. Diagnostic accuracy of cytology and immunocytology in carcinomatous effusion[J].Cy topathology,2008,(04):205-211.
  • 5Jang KY,Kang MJ,Lee DG. Utility of thyToid transcription factor-1 and cytokeratin7 and 20 immunostaining in the identification of origin in malignant effusions[J].Analytical and Quantitative Cytology and Histology,2001,(06):400-404.
  • 6Tsao SC,Su YC,Wang SL. Use of caveolin-1,thyroid transcription factor-1,and cytokeratins 7 and 20 in discriminating between primary and secondary pulmonary adenocarcinoma from breast or colonic origin[J].Kaohsiung Journal of Medical Sciences,2007,(07):325-331.
  • 7AI-Zahrani IH. The value of immunohistochemical expression of TTF-1,CK7 and CK20 in the diagnosis of primary and secondary lung carcinomas[J].Saudi Medical Journal,2008,(07):957-961.
  • 8Han L,Pansare V,Al-Abbadi M. Combination of MUC5ac and WT-1 immunohistochemistry is useful in distinguishing pancretic ductal carcinoma from ovarian serous carcinoma in effusion cytology[J].Diagnostic Cytopathology,2009.23.
  • 9方芳,杨丽,苏希来,贺青,刘冬戈,林凤如,马正中.浆膜腔积液中转移癌原发部位的细胞学研究[J].中华病理学杂志,2005,34(10):641-645. 被引量:18
  • 10Karafetic A,Jovanovic D,Jelic S. Expression of HER2./neu,estrogen and progesterone receptors,CA125 and CA19-9 on cancer cell membrane in patients with serous and mucinous carcinoma of the ovary[J].J BUON,2009,(04):635-639.

二级参考文献15

  • 1Loy TS, Quesenberry JY, Sharp SC.Distribution of CA125 in adenocarcinomas.An immunohistochemical study of 481 cases. Am J Clin Pathol,1992,98:175-179.
  • 2Skov RV, Bichel P.OC-125 as a diagnostic aid in the cytological evaluation of ascitic cells in patients with ovarian carcinoma. Virchows Arch A Pathol Anat Histopathol,1991,419:59-62.
  • 3Johnston WW. The malignant pleural effusion. A review of cytopathology diagnosis of 584 specimens from 472 consecutive patients. Cancer,1985,56:905-909.
  • 4Sears D, Hajdu SI. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions.Acta Cytol,1987,31:85-97.
  • 5Nance KV, Shermer RW, Askin FB. Diagnostic efficacy of pleural biopsy as compared with that of pleural fluid examination. Mod Pathol,1991,4:320-324.
  • 6Fenton KN, Richardson JD. Diagnosis and management of malignant pleural effusion. Am J Surg,1995,170:69-74.
  • 7Brown RW, Campagna LB, Dunn JK,et al.Immunohistochemical identification of tumor markers in metastatic adenocarcinoma.A diagnostic adjunct in the determination of primary site. Am J Clin Pathol,1997,107:12-19.
  • 8Longatto Filho A,Alves VA,Kanamura CT.Identification of the primary site of metastatic adenocarcinoma in serous effusion. Acta Cytol,2002,46:651-657.
  • 9Wiley EL,Von Roenn J. Metastatic breast carcinoma in pleural fluid.Correlation of morphology with estrogen receptor activity and morphology of the primary carcinoma.Acta Cytol,1990,34:169-174.
  • 10Mallonee MM,Lin F,Hassanein R. A morphologic analysis of the cells of ductal carcinoma of the breast and of adenocarcinoma of the ovary in pleural and abdominal effusions. Acta Cytol,1987,31:441-447.

共引文献17

同被引文献61

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部